INFLAMMATORY BOWEL DISEASE

Mahaprani Danastri; I Gusti Ayu; Darma Putra; Ida Bagus

首页> 外文期刊>e-Jurnal Medika Udayana >INFLAMMATORY BOWEL DISEASE

【24h】

INFLAMMATORY BOWEL DISEASE

机译：炎症性肠病

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Crohn disease (CD) and ulcerative colitis (UC) is an chronic inflammation in the gastrointestinal tract. Colecctively, they are called inflammatory bowel disease (IBD), and about 1,5 millions people in America suffering from UC and CD. The cause of UC and CD is unknown, but the expert believe that UC and CD are caused by a disturbed immune response in someone who has a genetic predisposition. UC and CD have a significant recurrency and remission rate. Surgery in UC is a curative treatment for colon’s disease and a potentially colon’s malignancy, but it is not a curative treatment for CD.

机译：克罗恩病（CD）和溃疡性结肠炎（UC）是胃肠道的慢性炎症。强迫性地，它们被称为炎症性肠病（IBD），在美国大约有1,500万人患有UC和CD。 UC和CD的病因尚不清楚，但专家认为UC和CD是由具有遗传易感性的人的免疫应答紊乱引起的。 UC和CD具有很高的复发率和缓解率。 UC手术是治疗结肠疾病和潜在的结肠恶性肿瘤的有效方法，但不是CD的有效治疗方法。

著录项

来源
《e-Jurnal Medika Udayana》 |2013年第1期|共32页
作者
Mahaprani Danastri; I Gusti Ayu; Darma Putra; Ida Bagus;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Immunosuppression increases the risk of lymphoproliferative diseases in chronic inflammatory bowel diseases: In a French prospective cohort study, a considerably increased relative risk of developing lymphoprolative diseases in patients with chronic inflammatory bowel diseases under therapy with thiopurines is manifested [J] . Medizinische Klinik . 2010,第6期

机译：免疫抑制会增加慢性炎症性肠病中淋巴增生性疾病的风险：在法国的一项前瞻性队列研究中，在用硫嘌呤治疗的慢性炎症性肠病患者中，发展成淋巴结性疾病的相对风险显着增加
2. Green tea: A possibility in the therapeutic approach of inflammatory bowel diseases? Green tea and inflammatory bowel diseases [J] . Barbalho Sandra Maria, Bosso Henrique, Salzedas-Pescinini Leticia M., Complementary therapies in medicine . 2019,第期

机译：绿茶：炎症性肠病治疗方法的可能性？绿茶和炎症性肠病疾病
3. Infliximab Biosimilar (Remsima (TM)) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases Centre [J] . Kolar M., Duricova D., Bortlik M., Digestive diseases . 2017,第1a2期

机译：炎症性肠病患者治疗中嗜活增生生物仿生（Remsima（TM））：来自一个炎症性肠病中心的经验
4. Large bowel standards: quality, polyps, inflammatory bowel disease, stenoses, conventional chromoendoscopy [C] . J. REGULA Falk Symposium . 2009

机译：大肠标准：质量，息肉，炎症性肠病，狭窄，常规复态镜检查
5. The Effect of Bowel Preparations on the Bacterial Flora of the Colon in Healthy Subjects and in Patients with Inflammatory Bowel Disease [D] . Shobar, Rima M. 2012

机译：肠道制剂对健康受试者中结肠菌细菌植物菌的影响和炎症性肠病患者
6. Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study [O] . Lorenz Grob, Sena Bluemel, Luc Biedermann, 2020

机译：在瑞士炎症性肠病队列研究中距离专科护理对炎症性肠病的诊断和疾病结局的影响
7. Qualidade de vida em pacientes portadores de doença inflamatória intestinal: tradução para o português e validação do questionário "Inflammatory Bowel Disease Questionnaire" (IBDQ) Quality of life in patients with inflammatory bowel diseases: translation to Portuguese language and validation of the "Inflammatory Bowel Disease Questionnaire" (IBDQ) [O] . Rose Meire Albuquerque Pontes, Sender Jankiel Miszputen, Olavo Franco Ferreira-Filho, 2004

机译：炎症性肠病患者的生活质量：葡萄牙语翻译和验证“炎症性肠病问卷”（IBDQ）炎症性肠病患者的生活质量：葡萄牙语翻译和“炎症性肠病”的验证调查问卷“（IBDQ）

INFLAMMATORY BOWEL DISEASE

摘要

著录项

相似文献

相关主题

期刊订阅